EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Necroptosis: The Regulation Between EGFR and TNFR in Cancer

Jin Gyeom Kim, Wook Jin iD

Cells · 22.07.2026 · 15 (14) · 1310

DOI: 10.3390/cells15141310 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cells, online erschienen am 22.07.2026. Verfasst von Jin Gyeom Kim und 1 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Molecular Disease and Cell Regulation, Department of Biochemistry, School of Medicine, Gachon University, Incheon 21999, Republic of Ko…. Hauptthemen laut MEDLINE: Necroptosis, ErbB Receptors, Neoplasms, Receptors, Tumor Necrosis Factor. Die Arbeit nennt 181 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea, Gachon University, Gachon University Research Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Most cancers are fatal and remain challenging to cure due to changes in tumorigenesis and therapeutic resistance. Despite significant advancements in cancer therapy, a substantial proportion of malignancies exhibit resistance to conventional therapies, driven primarily by cancer plasticity and the emergence of multidrug resistance. Recent cancer treatments include cytotoxic chemotherapy, molecular targeted therapy, and immune checkpoint inhibitors. A major hallmark of cancer cells is their ability to develop sophisticated evasion mechanisms that bypass programmed cell death when exposed to anti-cancer drugs. In addition, malignant cells evade the efficacy of anti-cancer drugs by altering cell proliferation, survival, and metastasis. To suppress oncogenic characteristics, necroptosis-based therapies have attracted substantial attention, as they can inhibit tumorigenesis and improve treatment outcomes across many cancer types. Furthermore, an increasing body of research focuses on suppressing tumorigenesis by targeting receptors that are overexpressed in cancer cells. In this review, we elucidate how tumorigenesis is inhibited by regulating the epidermal growth factor receptor (EGFR)–tumor necrosis factor receptor (TNFR) signaling pathway in necroptosis. By delineating the underlying mechanisms of these receptors, we propose that the induction of necroptosis via EGFR and TNFR represents an innovative paradigm for targeted therapy, offering a strategy to enhance clinical outcomes in treatment-resistant cancers.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NecroptosisErbB ReceptorsNeoplasmsReceptors, Tumor Necrosis FactorHumansAnimalsSignal Transduction

Stichwörter der Autor:innen

EGFRTNFRbreast cancernecroptosis

Substanzen

ErbB ReceptorsReceptors, Tumor Necrosis FactorEGFR protein, human

Autor:innen und Institutionen

  • Laboratory of Molecular Disease and Cell Regulation, Department of Biochemistry, School of Medicine, Gachon University, Incheon 21999, Republic of Korea.
  • Department of Health Sciences and Technology, GAIHST, Gachon University, Incheon 21999, Republic of Korea.

ORCID-Profile: Wook Jin

Förderung

  • National Research Foundation of Korea
  • Gachon University
  • Gachon University Research Foundation

Zitieren

APA

Kim, J. G., & Jin, W. (2026). Necroptosis: The Regulation Between EGFR and TNFR in Cancer. Cells, 15(14), 1310. https://doi.org/10.3390/cells15141310

Vancouver

Kim JG, Jin W. Necroptosis: The Regulation Between EGFR and TNFR in Cancer. Cells. 2026;15(14):1310. doi:10.3390/cells15141310

BibTeX
@article{Kim2026,
  author = {Kim, Jin Gyeom and Jin, Wook},
  title = {Necroptosis: The Regulation Between EGFR and TNFR in Cancer},
  journal = {Cells},
  year = {2026},
  volume = {15},
  number = {14},
  pages = {1310},
  doi = {10.3390/cells15141310}
}
Kostenlos starten →